The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease-Reference-Cited by-同舟云学术

The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease

Published:2009-11 Issue:6 Volume:88 Page:358-365
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Gonzalez-Juanatey Carlos,Vazquez-Rodriguez Tomas R.,Miranda-Filloy Jose A.,Dierssen Trinidad,Vaqueiro Ines,Blanco Ricardo,Martin Javier,Llorca Javier,Gonzalez-Gay Miguel A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference32 articles.

1. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study.;Bots;Ann Epidemiol,1996

2. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.;Calin;J Rheumatol,1994

3. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls.;Choe;Joint Bone Spine,2008

4. Acceleration of atherosclerosis during the course of rheumatoid arthritis.;Del Rincon;Atherosclerosis,2007

5. High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional cardiac risk factors.;Del Rincon;Arthritis Rheum,2001

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis;Seminars in Arthritis and Rheumatism;2024-10

2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up;Seminars in Arthritis and Rheumatism;2024-06

3. Increased carotid intima-media thickness in patients with radiographic axial spondyloarthritis compared to controls and associations with markers of inflammation;Clinical Rheumatology;2024-03-06

4. Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis;Medicine;2024-01-19

5. Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments;Current Opinion in Rheumatology;2023-12-20